GNRH1 and malignant colon neoplasm: The highly encouraging results described here regarding GnRH-AIF chimeric protein’s killing specificity and efficacy in vitro against human target cancer cells lines and ex vitro in human colon cancer organoid models suggest it as a novel treatment for solid cancers overexpressing the GnRH-R.